Related Experiment Video
Updated: Jul 12, 2026

09:52
A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
Published on: August 8, 2014
17.6K
Endothelial Insulin Resistance Exacerbates Experimental Periodontitis
1Section of Periodontology, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
Journal of Dental Research
|July 14, 2023
Summary
Endothelial insulin resistance in the gingiva promotes periodontitis by increasing VCAM1 expression and leukocyte adhesion. This occurs via reduced PI3K/Akt/FoxO1 pathway activation, worsening alveolar bone loss.
Area of Science:
- Oral Biology
- Endocrinology
- Immunology
Background:
- Periodontitis severity is higher in individuals with diabetes.
- Molecular mechanisms of diabetes-related periodontitis are unclear.
- Insulin resistance in gingival tissues may contribute to diabetic complications.
Purpose of the Study:
- Investigate endothelial insulin resistance in the gingiva's role in periodontitis pathogenesis.
- Elucidate the molecular mechanisms linking endothelial insulin resistance to periodontitis.
Main Methods:
- Examined insulin's effect on VCAM1 expression in endothelial cells (ECs) via the PI3K/Akt pathway.
- Utilized vascular endothelial cell-specific insulin receptor knockout (VEIRKO) mice.
- Analyzed the role of FoxO1 in insulin-mediated regulation of VCAM1 and leukocyte adhesion.
Main Results:
- Insulin treatment downregulated VCAM1 expression in ECs via PI3K/Akt, reducing leukocyte adhesion.
- Hyperglycemia-induced insulin resistance in ECs diminished insulin's effect on VCAM1.
- VEIRKO mice showed increased periodontitis and bone loss, with upregulated VCAM1, TNFα, MCP-1, and RANKL.
- Insulin-mediated FoxO1 activation was suppressed in VEIRKO mice and hyperglycemia-treated ECs.
- Mutated FoxO1 attenuated insulin's regulation of VCAM1 and leukocyte adhesion.
Conclusions:
- Endothelial insulin resistance contributes to periodontitis progression.
- Dysregulated VCAM1 expression and leukocyte adhesion result from impaired PI3K/Akt/FoxO1 signaling.
- Targeting endothelial insulin resistance may offer therapeutic strategies for periodontitis in diabetic patients.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

